APA (7th ed.) Citation

S, S., P, B., A, C., I, L., S, R., MM, M., . . . R, F. (2022). Cannabidiol and Terpene Formulation Reducing SARS-CoV-2 Infectivity Tackling a Therapeutic Strategy. Frontiers in immunology, 13, 841459. https://doi.org/10.3389/fimmu.2022.841459

Chicago Style (17th ed.) Citation

S, Santos, et al. "Cannabidiol and Terpene Formulation Reducing SARS-CoV-2 Infectivity Tackling a Therapeutic Strategy." Frontiers in Immunology 13 (2022): 841459. https://doi.org/10.3389/fimmu.2022.841459.

MLA (9th ed.) Citation

S, Santos, et al. "Cannabidiol and Terpene Formulation Reducing SARS-CoV-2 Infectivity Tackling a Therapeutic Strategy." Frontiers in Immunology, vol. 13, 2022, p. 841459, https://doi.org/10.3389/fimmu.2022.841459.